MedTrace Logo

Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque

NCT00760786 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-09-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether intensive lipid lowering and Omega-3 fatty acid are effective in the treatment of coronary atherosclerotic plaque.

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Intensive lipid lowering plus Omega3-fatty acid

Atorvastatin 40mg qd plus Omega3-fatty acid 2.0mg qd

DRUG

Moderate lipid lowering plus Omega3-fatty acid

atorvastatin 10mg qd plus Omega3-fatty acid 2.0mg qd

DRUG

Intensive lipid lowering plus placebo

atorvastatin 40mg qd

DRUG

Moderate lipid lowering plus placebo

atorvastatin 10mg qd

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Joo-Yong Han, Professor · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00760786 on ClinicalTrials.gov